Literature DB >> 8100055

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats.

D A Daly1, B Moghaddam.   

Abstract

The technique of intracerebral microdialysis was employed to assess the effect of acute clozapine and haloperidol on the extracellular levels of aspartate and glutamate in the striatum and medial prefrontal cortex of conscious rats. Subcutaneous injection of 25 mg/kg clozapine, but not the lower dose of 15 mg/kg, led to a significant increase in both aspartate and glutamate levels over time. The maximum effect was observed two hours after injection. Haloperidol (0.5 and 1 mg/kg s.c.) did not increase the extracellular levels of aspartate and glutamate over time. At all doses tested, both drugs were without a significant effect in the striatum. These data suggest that clozapine may have selective actions on the cortical excitatory amino acid systems.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100055     DOI: 10.1016/0304-3940(93)90483-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

Review 1.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

2.  Differential effects of clozapine and haloperidol on interval timing in the supraseconds range.

Authors:  Christopher J MacDonald; Warren H Meck
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 3.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

4.  Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.

Authors:  Katarzyna Fijał; Piotr Popik; Agnieszka Nikiforuk
Journal:  Psychopharmacology (Berl)       Date:  2013-08-18       Impact factor: 4.530

Review 5.  Cognitive effects of second-generation antipsychotics: current insights into neurochemical mechanisms.

Authors:  Fabio Fumagalli; Angelisa Frasca; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 6.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

7.  Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome.

Authors:  Monica E Lemmon; Marco Grados; Tina Kline; Carol B Thompson; Syed F Ali; Harvey S Singer
Journal:  Pediatr Neurol       Date:  2015-02-19       Impact factor: 3.372

Review 8.  The potential role of lamotrigine in schizophrenia.

Authors:  Charles H Large; Elizabeth L Webster; Donald C Goff
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

9.  The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.

Authors:  Mei Huang; Anna R Felix; Dorothy G Flood; Chaya Bhuvaneswaran; Dana Hilt; Gerhard Koenig; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

10.  Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors.

Authors:  Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  2007-10-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.